Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

US Patent 10677786 · Granted Jun 9, 2020

Estimated economic value: $149,628,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellular glycosaminoglycan compositions and methods of making and using2023
Organophosphate derivatives2022
Nanoparticle compositions2022
Compositions for the treatment of autodigestion2021
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Detection of oligosaccharides2020
Detection of oligosaccharides2020
Detection of oligosaccharides2020